BofA Securities analyst Joshua Dennerlein maintains $American Healthcare REIT (AHR.US)$ with a buy rating, and sets the target price at $36.
According to TipRanks data, the analyst has a success rate of 42.5% and a total average return of 0.6% over the past year.
Furthermore, according to the comprehensive report, the opinions of $American Healthcare REIT (AHR.US)$'s main analysts recently are as follows:
American Healthcare REIT's recent quarterly performance surpassed expectations and led to a revised FY24 earnings forecast, now anticipated at $1.40-$1.43, marking a 13% midpoint increase over prior estimates. The guidance for total same-store NOI was also raised to 16%, which is viewed as conservative. The company continues to be regarded persistently as a key player in its sector.
American Healthcare REIT is currently poised to achieve robust organic growth while benefiting from the favorable conditions in seniors housing and skilled nursing facilities. Although a conservative approach is still being maintained regarding new investment expectations, the company is now more favorably aligned to pursue accretive investments.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美銀證券分析師Joshua Dennerlein維持$American Healthcare REIT (AHR.US)$買入評級，目標價36美元。
根據TipRanks數據顯示，該分析師近一年總勝率為42.5%，總平均回報率為0.6%。
此外，綜合報道，$American Healthcare REIT (AHR.US)$近期主要分析師觀點如下：
美國醫療房地產投資信託最近的季度業績超出預期，導致對2024財年的收益預測進行了修訂，現在預計在1.40-1.43美元之間，比之前的估計中值增加了13%。對總同店淨營業收入（NOI）的指導也提高到16%，這被視爲保守的。該公司繼續被認爲是在其板塊中的關鍵參與者。
美國醫療房地產投資信託目前有望實現強勁的有機增長，同時受益於老年住房和熟練護理設施的有利條件。儘管對新投資預期仍然保持保守態度，但該公司現在更有利於追求增值投資。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
